Templates by BIGtheme NET
Healthcare-cropped

HC Stocks in Hub! Johnson & Johnson (JNJ), Celgene (CELG)

Shares of Johnson & Johnson (NYSE:JNJ) ended Monday session in green amid volatile trading. The shares closed up +0.68 points or 0.58% at $118.81 with 6.10 million shares getting traded. Post opening the session at $118.00, the shares hit an intraday low of $117.43 and an intraday high of $119.01 and the price vacillated in this range throughout the day. The company has a market cap of $327.43 billion and the numbers of outstanding shares have been calculated to be 2.74 billion shares.

Johnson & Johnson (JNJ) announced that it will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, to review third-quarter results.  Dominic Caruso, Executive Vice President, Chief Financial Officer, Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals, Dr. William Hait, MD. PhD, Global Head Janssen Research & Development, LLC, and Joseph J. Wolk, Vice President, Investor Relations, will host the call.

Investors and other interested parties may access the conference call in the following ways:

The webcast is accessible at Johnson & Johnson’s website: www.investor.jnj.com. A webcast and podcast replay will be available approximately one hour after the conference call concludes.

By telephone:  for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847.  For participants outside the U.S., the dial-in number is 201-689-8261.

A replay of the conference call will be available until approximately 12:00 a.m. on October 25, 2016. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13645877.

Presentation materials will be available on www.investor.jnj.com.

The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.

Shares of Celgene Corporation (NASDAQ:CELG) ended Monday session in red amid volatile trading. The shares closed down -0.26 points or -0.25% at $104.27 with 2.59 million shares getting traded. Post opening the session at $104.15, the shares hit an intraday low of $103.01 and an intraday high of $104.53 and the price vacillated in this range throughout the day. The company has a market cap of $82.21 billion and the numbers of outstanding shares have been calculated to be 775.11 million shares.

Celgene Corporation (CELG) announced that it will host a conference call and live audio webcast on Thursday, October 27, 2016 at 9 a.m. ET to discuss third quarter 2016 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.

 

 

 

About James Smith

James Smith is one of the best author of health care. His articles have appeared in a number of health care sites before and now he is writing on health care for us on regular basis.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

ăn dặm kiểu NhậtResponsive WordPress Themenhà cấp 4 nông thônthời trang trẻ emgiày cao gótshop giày nữdownload wordpress pluginsmẫu biệt thự đẹpepichouseáo sơ mi nữhouse beautiful